András Visegrádi

Title: András Visegrádi: Innovator in Thiadiazine Derivatives

Introduction

András Visegrádi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his work on thiadiazine derivatives. His innovative approach has led to advancements in the modulation of nicotinic acetylcholine receptors, which are crucial for various biological functions.

Latest Patents

András Visegrádi holds 1 patent related to thiadiazine derivatives. This invention encompasses not only the derivatives themselves but also their pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates, and hydrates. The patent also details pharmaceutical compositions containing these compounds and their application as modulators of α7 nicotinic acetylcholine receptor activity in mammalian subjects.

Career Highlights

Visegrádi is associated with Richter Gedeon Nyrt., a prominent pharmaceutical company. His work there has been instrumental in developing new therapeutic agents that target critical biological pathways. His expertise in medicinal chemistry has positioned him as a key player in the pharmaceutical innovation landscape.

Collaborations

Throughout his career, András has collaborated with esteemed colleagues such as István Ledneczki and János Éles. These partnerships have fostered a collaborative environment that enhances research and development efforts within the company.

Conclusion

András Visegrádi's contributions to the field of pharmaceuticals through his work on thiadiazine derivatives exemplify the impact of innovative thinking in medicine. His ongoing efforts continue to pave the way for new therapeutic solutions.